PBMs face scrutiny from all sides, and analyzing Marty Makary’s road to the FDA

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Congress nears spending deal with long-awaited PBM reforms

Congress is on the edge of a deal that would reshape pharmacy benefit managers, extend telehealth access, and renew certain public health authorities.

advertisement

The language of the government funding package has not been publicly released as of Monday night and could still change, but sources indicate some longtime health care policy priorities are making the cut for the year-end spending deal, Rachel Cohrs Zhang reports.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe